Study of White Blood Cells in Donors and Patients
Part of Immune system & allergy clinical trials.
This study looks at white blood cells (the body’s immune cells) to learn more about how they behave in health and/or illness. Participation may help researchers understand immune-related changes and support future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being asked to join through an institution that has consented to the study
- You must meet whatever inclusion and exclusion rules your consenting site applies
- You must be able to give informed consent (agree to participate)
- You may be asked for blood samples or other specimen collection related to white blood cells
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood cells and bone marrow from people with immune system or blood disorders, and from healthy volunteers. Researchers will study these cells and may convert them into special stem cells (iPS cells) to better understand diseases and develop treatments.
This study tests a better way to collect white blood cells from healthy people who donate blood. It may help improve how reliably and safely white blood cells are collected for research or future treatments.
This study looks at how your immune system “rebuilds” after certain cell-based cancer treatments or stem cell transplants. It may help researchers better understand why immune recovery differs between people and how to improve protection against infections.
This trial is a tissue and blood bank that collects samples for future research. You may be asked to give blood and/or tissue again later, but it is meant to be done without interfering with your care.
This study collects white blood cells from healthy volunteers every 56 days to help researchers understand how aging affects the immune system. Your cells will be studied in a lab to learn more about natural aging processes.
This study looks at natural killer (NK) cells, which are part of the immune system, in the blood of people who have had a stem cell transplant for acute leukemia or myelodysplasia. It aims to understand how these cells change after transplant and potentially predict outcomes.
Hear when a new Autoimmune Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.